1912 related articles for article (PubMed ID: 17674108)
21. [Ductal carcinoma in situ of the breast with microinvasion. Role of sentinel lymph node biopsy].
Le Bouëdec G; de Lapasse C; Mishellany F; Chêne G; Michy T; Gimbergues P; Dauplat J
Gynecol Obstet Fertil; 2007 Apr; 35(4):317-22. PubMed ID: 17344087
[TBL] [Abstract][Full Text] [Related]
22. Ductal carcinoma in situ: value of sentinel lymph node biopsy.
Sakr R; Barranger E; Antoine M; Prugnolle H; Daraï E; Uzan S
J Surg Oncol; 2006 Oct; 94(5):426-30. PubMed ID: 16967457
[TBL] [Abstract][Full Text] [Related]
23. [Comparison of sentinel lymph node detection by methylene blue and carbon nanoparticle suspension injection in early breast cancer].
Ge J; Yan B; Cao XC
Zhonghua Zhong Liu Za Zhi; 2011 Mar; 33(3):226-8. PubMed ID: 21575525
[TBL] [Abstract][Full Text] [Related]
24. The role of sentinel node biopsy in ductal carcinoma in situ of the breast.
Polom K; Murawa D; Wasiewicz J; Nowakowski W; Murawa P
Eur J Surg Oncol; 2009 Jan; 35(1):43-7. PubMed ID: 18723312
[TBL] [Abstract][Full Text] [Related]
25. [Importance of sentinel lymph node biopsy in surgical therapy of in situ breast cancer].
Takács T; Szentpáli K; Paszt A; Ormándi K; Lázár M; Pálka I; Kahán Z; Lázár G
Magy Onkol; 2006; 50(3):247-51. PubMed ID: 17099786
[TBL] [Abstract][Full Text] [Related]
26. Occult lesions of the breast.
Poole GV; Choplin RH; Sterchi JM; Leinbach LB; Myers RT
Surg Gynecol Obstet; 1986 Aug; 163(2):107-10. PubMed ID: 3016925
[TBL] [Abstract][Full Text] [Related]
27. Sentinel node positive breast cancer patients who do not undergo axillary dissection: are they different?
Zakaria S; Pantvaidya G; Reynolds CA; Grant CS; Sterioff S; Donohue JH; Farley DR; Hoskin TL; Degnim AC
Surgery; 2008 May; 143(5):641-7. PubMed ID: 18436012
[TBL] [Abstract][Full Text] [Related]
28. Isolated retromammary lymph node metastasis of breast cancer without axillary lymph node involvement: a case report with a false-negative sentinel lymph node biopsy.
Rokutanda N; Horiguchi J; Koibuchi Y; Nagaoka R; Sato A; Odawara H; Tokiniwa H; Iino Y; Hirato J; Takeyoshi I
Breast Cancer; 2009; 16(2):162-5. PubMed ID: 19242778
[TBL] [Abstract][Full Text] [Related]
29. Nonpalpable versus palpable invasive breast tumors treated with breast-conserving surgical management.
Tafra L; Essner R; Brenner RJ; Giuliano AE
Am Surg; 1996 May; 62(5):395-9. PubMed ID: 8615571
[TBL] [Abstract][Full Text] [Related]
30. Risk of invasion and axillary lymph node metastasis in ductal carcinoma in situ diagnosed by core-needle biopsy.
Meijnen P; Oldenburg HS; Loo CE; Nieweg OE; Peterse JL; Rutgers EJ
Br J Surg; 2007 Aug; 94(8):952-6. PubMed ID: 17440955
[TBL] [Abstract][Full Text] [Related]
31. Minimal access breast surgery: a single breast incision for breast conservation surgery and sentinel lymph node biopsy.
Spillane AJ; Brennan ME
Eur J Surg Oncol; 2009 Apr; 35(4):380-6. PubMed ID: 18757165
[TBL] [Abstract][Full Text] [Related]
32. Axillary lymphectomy in breast cancer.
Barillari P; Leuzzi R; D'Angelo F; Bassiri-Gharb A; Naticchioni E
Minerva Chir; 2002 Apr; 57(2):129-33. PubMed ID: 11941288
[TBL] [Abstract][Full Text] [Related]
33. The feasibility of intraoperative diagnosis of sentinel lymph node metastases in breast cancer.
Leidenius MH; Krogerus LA; Toivonen TS; Von Smitten KJ
J Surg Oncol; 2003 Oct; 84(2):68-73. PubMed ID: 14502779
[TBL] [Abstract][Full Text] [Related]
34. Combined radioguided nonpalpable lesion localization and sentinel lymph node biopsy for early breast carcinoma.
Barros AC; Barros MA; Andrade FE; Mori LJ; Costa PA; Sheng PY; Pelizon CH
Ann Surg Oncol; 2007 Apr; 14(4):1472-7. PubMed ID: 17225979
[TBL] [Abstract][Full Text] [Related]
35. [Prognostic and curative value of sentinel node in breast cancer. A 377 patients experience].
Iannace C; Di Libero L; Lepore M; De Stefano N; Buono M; Sciascia V; Manetta F; Giordano M; Scetta G; Varriale R; Esposito D; Tartaglia E; Ferbo U; Miletto P; Caracciolo F
Ann Ital Chir; 2010; 81(2):103-11; discussion 112-3. PubMed ID: 20726388
[TBL] [Abstract][Full Text] [Related]
36. Reliability and validity of needle biopsy evaluation of breast-abnormalities using the B-categorization--design and objectives of the Diagnosis Optimisation Study (DIOS).
Kluttig A; Trocchi P; Heinig A; Holzhausen HJ; Taege C; Hauptmann S; Boecker W; Decker T; Loening T; Schmidt-Pokrzywniak A; Thomssen C; Lantzsch T; Buchmann J; Stang A
BMC Cancer; 2007 Jun; 7():100. PubMed ID: 17570833
[TBL] [Abstract][Full Text] [Related]
37. The feasibility of sentinel node biopsy in the previously treated breast.
Koizumi M; Koyama M; Tada K; Nishimura S; Miyagi Y; Makita M; Yoshimoto M; Iwase T; Horii R; Akiyama F; Saga T
Eur J Surg Oncol; 2008 Apr; 34(4):365-8. PubMed ID: 17532172
[TBL] [Abstract][Full Text] [Related]
38. Is sentinel lymph node biopsy more accurate than axillary dissection for staging nodal involvement in breast cancer patients?
Marrazzo A; Taormina P; Gebbiab V; David M; Riili I; Lo Gerfo D; Casà L; Noto A
Chir Ital; 2007; 59(5):693-9. PubMed ID: 18019642
[TBL] [Abstract][Full Text] [Related]
39. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ.
Dominguez FJ; Golshan M; Black DM; Hughes KS; Gadd MA; Christian R; Lesnikoski BA; Specht M; Michaelson J; Smith BL
Ann Surg Oncol; 2008 Jan; 15(1):268-73. PubMed ID: 17891441
[TBL] [Abstract][Full Text] [Related]
40. Simultaneous use of an (125)I-seed to guide tumour excision and (99m)Tc-nanocolloid for sentinel node biopsy in non-palpable breast-conserving surgery.
Pouw B; van der Ploeg IM; Muller SH; Valdés Olmos RA; Janssen-Pinkse LK; Oldenburg HS; Vrancken Peeters MT
Eur J Surg Oncol; 2015 Jan; 41(1):71-8. PubMed ID: 25458078
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
